World's Best Scientists 2026 revealed!
Ross J. Baldessarini

Ross J. Baldessarini

D-Index & Metrics

Medicine

D-Index
143
Citations
70784
World Ranking
1520
National Ranking
883

Overview

Ross J. Baldessarini is affiliated with Harvard University in the United States and has a significant research portfolio primarily focused on psychiatric disorders, especially bipolar disorder. Their work spans medicine and psychology, with a concentration in psychiatry and mental health as well as clinical psychology and pharmacology.

The scientist has contributed extensively to topics including bipolar disorder and its treatment, schizophrenia research and treatment, electroconvulsive therapy studies, the treatment of major depression, suicide and self-harm studies, child and adolescent psychosocial and emotional development, and tryptophan and brain disorders.

Notable recent publications include:

  • Bipolar depression: a major unsolved challenge (2020), published in International Journal of Bipolar Disorders
  • The clinical characterization of the adult patient with bipolar disorder aimed at personalization of management (2022), published in World Psychiatry
  • Prevention of suicidal behavior in bipolar disorder (2020), published in Bipolar Disorders
  • Efficacy and Tolerability of Combination Treatments for Major Depression: Antidepressants plus Second-Generation Antipsychotics vs. Esketamine vs. Lithium (2021), published in Journal of Psychopharmacology
  • Preventing new episodes of bipolar disorder in adults: Systematic review and meta-analysis of randomized controlled trials (2021), published in European Neuropsychopharmacology

Frequent co-authors collaborating with Ross J. Baldessarini include Leonardo Tondo, Gustavo Vázquez, Alessandro Miola, Marco Pinna, and Martina Contu.

The researcher publishes regularly in venues such as the Journal of Clinical Psychopharmacology, Journal of Affective Disorders, International Journal of Bipolar Disorders, Journal of Psychopharmacology, and Acta Psychiatrica Scandinavica.

Their areas of focus within the field largely relate to understanding and managing bipolar disorder, as indicated by the high number of publications related to this topic, alongside other psychiatric conditions and treatments. Their work examines clinical characterization, prevention strategies, and pharmacological treatments to enhance patient outcomes.

Best Publications

  • International Consensus Study of Antipsychotic Dosing

    David M. Gardner;Andrea L. Murphy;Heather O'Donnell;Franca Centorrino

  • Practice guideline for the treatment of patients with schizophrenia

    M. I. Herz;R. P. Liberman;T. H. McGlashan;J. A. Lieberman

  • One hundred years of schizophrenia: a meta-analysis of the outcome literature.

    J D Hegarty;R J Baldessarini;M Tohen;C Waternaux

  • Clozapine. A novel antipsychotic agent.

    R J Baldessarini;F R Frankenburg

  • False neurotransmitters and hepatic failure.

    JosefE Fischer;RossJ Baldessarini

  • The International Society for bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders

    Isabella Pacchiarotti;David J. Bond;Ross J. Baldessarini;Willem A. Nolen

  • The Dexamethasone Suppression Test for Diagnosis and Prognosis in Psychiatry: Commentary and Review

    George W. Arana;Ross J. Baldessarini;Marjorie Ornsteen

  • Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review.

    Ross J Baldessarini;Leonardo Tondo;Leonardo Tondo;Paula Davis;Maurizio Pompili;Maurizio Pompili

  • Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychoses.

    Ross J. Baldessarini;Bruce M. Cohen;Martin H. Teicher

  • Two-Year Syndromal and Functional Recovery in 219 Cases of First-Episode Major Affective Disorder With Psychotic Features

    Mauricio Tohen;John Hennen;Carlos M. Zarate;Ross J. Baldessarini

  • Behavioural supersensitivity to apomorphine following chronic treatment with drugs which interfere with the synaptic function of catecholamines.

    D. Tarsy;R.J. Baldessarini;R.J. Baldessarini

  • Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation

    Adele C. Viguera;Theodore Whitfield;Ross J. Baldessarini;D. Jeffrey Newport

  • The McLean-Harvard first-episode mania study: Prediction of recovery and first recurrence

    Mauricio Tohen;Carlos A. Zarate;John Hennen;Hari Mandir Kaur Khalsa

  • Neuroleptic withdrawal in schizophrenic patients. A review of the literature.

    P L Gilbert;M J Harris;L A McAdams;D V Jeste

  • The predictive power of diagnostic tests and the effect of prevalence of illness

    Ross J. Baldessarini;Seth Finklestein;George W. Arana

  • Risk of recurrence following discontinuation of lithium treatment in bipolar disorder.

    Trisha Suppes;Ross J. Baldessarini;Gianni L. Faedda;Mauricio Tohen

  • Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance.

    Adele C. Viguera;Ruta Nonacs;Lee S. Cohen;Leonardo Tondo

  • Suicidal behaviour in bipolar disorder: risk and prevention

    Leonardo Tondo;Leonardo Tondo;Göran Isacsson;Ross J. Baldessarini

  • Modern antipsychotic drugs: a critical overview

    David M. Gardner;Ross J. Baldessarini;Paul Waraich

  • Animal models of attention-deficit hyperactivity disorder

    Eugen Davids;Kehong Zhang;Frank I Tarazi;Ross J Baldessarini

Frequent Co-Authors

Leonardo Tondo
Leonardo Tondo University of Cagliari
John L. Neumeyer
John L. Neumeyer Harvard University
Mauricio Tohen
Mauricio Tohen University of New Mexico
Frank I. Tarazi
Frank I. Tarazi Harvard University
John Hennen
John Hennen Harvard University
Gustavo H. Vázquez
Gustavo H. Vázquez Queen's University
Eduard Vieta
Eduard Vieta University of Barcelona
Maurizio Pompili
Maurizio Pompili Sapienza University of Rome
Martin H. Teicher
Martin H. Teicher Harvard University
Paolo Girardi
Paolo Girardi Sapienza University of Rome

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a career in healthcare doesn’t always mean you need to attend traditional, on-campus medical school. Today, there are diverse online educational pathways that can help you enter the medical field or advance your healthcare career. For example, online bsn programs for non nurses offer flexible options for those who hold a bachelor’s degree in another field and want to become registered nurses.

Not all roles in healthcare require direct patient care or clinical training. If you’re interested in administrative or coding positions, there are a variety of medical billing and coding schools that accept financial aid. These programs are ideal for students seeking to work remotely or behind the scenes in healthcare settings.

Some prospective nurses may be concerned about standardized tests. If so, you may wish to explore schools where do you have to take a teas test for lpn is not a requirement, making it easier to start your nursing education journey.

For those interested in management, leadership, or policy roles, there are healthcare administration programs available online, often in accelerated formats. These prepare graduates for vital non-clinical positions in hospitals, clinics, and medical offices.

Best Scientists Citing Ross J. Baldessarini

Trending Scientists

Recently Published Articles